Session II: Advances in Fistulizing Crohn’s Disease: Emerging Therapies and Patient-Centric Management Strategies
Thursday, September 14, 2023
2:30 PM – 3:15 PM .
This activity is supported by an educational grant from Takeda Pharmaceuticals U.S.A.
Learning Objectives:
Describe the burden, unmet needs, and management challenges associated with fistulizing CD
Evaluate the most recent clinical data associated with newer and emerging therapies for fistulizing CD
Implement coordinated, patient-centered management strategies based on the most current evidence and consensus-based guidelines for the management of fistulizing CD